Tomosynthesis reduces breast screening recall rates

Tomosynthesis is effective at reducing recall rates in breast cancer screening, according to a new study published online in Radiology.

In the study, Brian Haas, M.D., and Liane Philpotts from the Yale School of Medicine, along with other colleagues, compared recall and cancer detection rates in two groups of women: those receiving digital mammography alone and those who underwent tomosynthesis, as well as mammography.

The cancer detection rate was 5.7 per 1,000 in patients receiving tomosynthesis, compared with 5.2 per 1,000 in patients receiving mammography alone. The addition of tomosynthesis resulted in a 30 percent reduction in the overall recall rate, from 12.0 percent for mammography alone to 8.4 percent in the tomosynthesis group.

"All age groups and breast densities had reduced risk for recall in the tomosynthesis group," Haas said. "Women with dense breasts and those younger than age 50 particularly benefited from tomosynthesis." He added that fewer recalls reduces cost as well as patient anxiety. Announcement

Suggested Articles

Women and family health startup Maven landed $45 million in series C funding with some high-profile backers.

Over 41 million patient records were breached in 2019 as the healthcare industry faces new hacking techniques and threats.

With the promotion of Don Trigg, Cerner has named its first new president since 2018.